StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie scope 2 Purchased Electricity GHG Emissions (tCO2e)

AbbVie ESG Action Reports

Latest, FY2025
28,706.00
Period ended Dec 31, 2025
Change on a year earlier
-62.0%
75,539.00 in FY2024
History
5 years
Since FY2021
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedScope 2 Purchased Electricity GHG Emissions (tCO2e)Year on yearSource
FY2025Dec 31, 202528,706.00-62.0%AbbVie 2025 ESG Action Report ↗
FY2024Dec 31, 202475,539.00-12.1%AbbVie 2025 ESG Action Report ↗
FY2023Dec 31, 202385,935.00-36.4%AbbVie 2025 ESG Action Report ↗
FY2022Dec 31, 2022135,090.00-34.1%AbbVie 2023 ESG Action Report ↗
FY2021Dec 31, 2021204,918.00–AbbVie 2023 ESG Action Report ↗

Cite this data

StockData. (2026). AbbVie Scope 2 Purchased Electricity GHG Emissions (tCO2e), annual FY2021–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/esg_scope2_elec

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.